WBB Securities Upgrades Redhill Biopharma (RDHL) to Buy

March 12, 2019 8:55 AM EDT
Get Alerts RDHL Hot Sheet
Price: $4.84 --0%

Rating Summary:
    8 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 6 | Down: 4 | New: 30
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

WBB Securities analyst Steve Brozak upgraded Redhill Biopharma (NASDAQ: RDHL) from Speculative Buy to Buy with a price target of $17.00 (from $9.00).

For an analyst ratings summary and ratings history on Redhill Biopharma click here. For more ratings news on Redhill Biopharma click here.

Shares of Redhill Biopharma closed at $8.32 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change, Upgrades